Literature DB >> 21170122

Comparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonists.

P Senthil Kumar1, Prasad V Bharatam.   

Abstract

A quantitative structure-activity relationship study of tryptamine-based derivatives of β(1)-, β(2)-, and β(3)-adrenoceptor agonists was conducted using comparative molecular field analysis (CoMFA). Correlation coefficients (cross-validated r(2)) of 0.578, 0.595, and 0.558 were obtained for the three subtypes, respectively, in three different CoMFA models. All three CoMFA models have different steric and electrostatic contributions, implying different requirements inside the binding cavity. The CoMFA coefficient contour plots of the three models and comparisons among these plots provide clues regarding the main chemical features responsible for the biological activity variations and also result in predictions which correlate very well with the observed biological activity. Based on the analysis, a summary regeospecific description of the requirements for improving β-adrenoceptor subtype selectivity is given.

Entities:  

Year:  2009        PMID: 21170122      PMCID: PMC2988205          DOI: 10.1007/s00044-009-9257-x

Source DB:  PubMed          Journal:  Med Chem Res        ISSN: 1054-2523            Impact factor:   1.965


  50 in total

Review 1.  Structural basis of G protein-coupled receptor function.

Authors:  T Schöneberg; G Schultz; T Gudermann
Journal:  Mol Cell Endocrinol       Date:  1999-05-25       Impact factor: 4.102

Review 2.  Beta-adrenoceptor agonists and asthma--100 years of development.

Authors:  Bertil Waldeck
Journal:  Eur J Pharmacol       Date:  2002-06-07       Impact factor: 4.432

3.  BMS-201620: a selective beta 3 agonist.

Authors:  W N Washburn; C-Q Sun; G Bisacchi; G Wu; P T Cheng; P M Sher; D Ryono; A V Gavai; K Poss; R N Girotra; P J McCann; A B Mikkilineni; T C Dejneka; T C Wang; Z Merchant; M Morella; C M Arbeeny; T W Harper; D A Slusarchyk; S Skwish; A D Russell; G T Allen; B Tesfamariam; B H Frohlich; B E Abboa-Offei; M Cap; T L Waldron; R J George; D Young; K E Dickinson; A A Seymour
Journal:  Bioorg Med Chem Lett       Date:  2004-07-05       Impact factor: 2.823

Review 4.  G-Protein coupled receptors: models, mutagenesis, and drug design.

Authors:  J A Bikker; S Trumpp-Kallmeyer; C Humblet
Journal:  J Med Chem       Date:  1998-07-30       Impact factor: 7.446

5.  (4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonists.

Authors:  B Hu; J Ellingboe; S Han; E Largis; R Mulvey; A Oliphant; F W Sum; J Tillett
Journal:  J Med Chem       Date:  2001-04-26       Impact factor: 7.446

6.  Tryptamine-based human beta3-adrenergic receptor agonists. Part 3: improved oral bioavailability via modification of the sulfonamide moiety.

Authors:  Masaaki Sawa; Kazuhiro Mizuno; Hiroshi Harada; Hirotaka Tateishi; Yukiyo Arai; Shinya Suzuki; Mayumi Oue; Hiroshi Tsujiuchi; Yasuji Furutani; Shiro Kato
Journal:  Bioorg Med Chem Lett       Date:  2005-02-15       Impact factor: 2.823

7.  Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta(3) agonists.

Authors:  B Hu; J Ellingboe; S Han; E Largis; K Lim; M Malamas; R Mulvey; C Niu; A Oliphant; J Pelletier; T Singanallore; F W Sum; J Tillett; V Wong
Journal:  Bioorg Med Chem       Date:  2001-08       Impact factor: 3.641

8.  Discovery of an orally bioavailable alkyl oxadiazole beta3 adrenergic receptor agonist.

Authors:  D D Feng; T Biftu; M R Candelore; M A Cascieri; L F Colwell; L Deng; W P Feeney; M J Forrest; G J Hom; D E MacIntyre; R R Miller; R A Stearns; C D Strader; L Tota; M J Wyvratt; M H Fisher; A E Weber
Journal:  Bioorg Med Chem Lett       Date:  2000-07-03       Impact factor: 2.823

9.  Characterization of beta3-adrenergic receptor: determination of pharmacophore and 3D QSAR model for beta3 adrenergic receptor agonism.

Authors:  Philip Prathipati; Anil K Saxena
Journal:  J Comput Aided Mol Des       Date:  2005-02       Impact factor: 3.686

10.  Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonist.

Authors:  E R Parmee; H O Ok; M R Candelore; L Tota; L Deng; C D Strader; M J Wyvratt; M H Fisher; A E Weber
Journal:  Bioorg Med Chem Lett       Date:  1998-05-05       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.